| A century of trends in adult human height NCD Risk Factor Collaboration (NCD-RisC) elife 5, e13410, 2016 | 618 | 2016 |
| Discordance between pain and radiographic severity in knee osteoarthritis: findings from quantitative sensory testing of central sensitization PH Finan, LF Buenaver, SC Bounds, S Hussain, RJ Park, UJ Haque, ... Arthritis & Rheumatism 65 (2), 363-372, 2013 | 487 | 2013 |
| The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes M Wei, L Ong, MT Smith, FB Ross, K Schmid, AJ Hoey, D Burstow, ... Heart, Lung and Circulation 12 (1), 44-50, 2003 | 425 | 2003 |
| Morphine-3-glucuronide-a potent antagonist of morphine analgesia MT Smith, JA Watt, T Cramond Life sciences 47 (6), 579-585, 1990 | 418 | 1990 |
| Sleep quality and presleep arousal in chronic pain MT Smith, ML Perlis, MS Smith, DE Giles, TP Carmody Journal of behavioral medicine 23, 1-13, 2000 | 408 | 2000 |
| First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: Systematic review and meta-analysis M Smith, D Hopkins, RC Peveler, RIG Holt, M Woodward, K Ismail The British Journal of Psychiatry 192 (6), 406-411, 2008 | 376 | 2008 |
| Bioerodable PLGA-based microparticles for producing sustained-release drug formulations and strategies for improving drug loading FY Han, KJ Thurecht, AK Whittaker, MT Smith Frontiers in pharmacology 7, 185, 2016 | 365 | 2016 |
| Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. MT Smith Clinical and experimental pharmacology & physiology 27 (7), 524-528, 2000 | 365 | 2000 |
| Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation K Shekar, JF Fraser, MT Smith, JA Roberts Journal of critical care 27 (6), 741. e9-741. e18, 2012 | 330 | 2012 |
| The pharmacokinetics of midazolam in man MT Smith, MJ Eadie, TOR Brophy European journal of clinical pharmacology 19, 271-278, 1981 | 320 | 1981 |
| Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN) Y Han, MT Smith Frontiers in pharmacology 4, 71202, 2013 | 316 | 2013 |
| The intrinsic antinociceptive effects of oxycodone appear to be κ-opioid receptor mediated FB Ross, MT Smith Pain 73 (2), 151-157, 1997 | 306 | 1997 |
| Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II OG Engelhardt, M Smith, E Fodor Journal of virology 79 (9), 5812-5818, 2005 | 299 | 2005 |
| Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation K Shekar, JA Roberts, CI Mcdonald, S Fisquet, AG Barnett, DV Mullany, ... Critical care 16, 1-7, 2012 | 270 | 2012 |
| Measurement of inclusive and differential cross sections in the H → ZZ * → 4ℓ decay channel in pp collisions at TeV with the ATLAS detector M Aaboud, G Aad, B Abbott, B Abeloos, SH Abidi, OS AbouZeid, ... Journal of High Energy Physics 2017 (10), 1-49, 2017 | 258 | 2017 |
| National Beef Quality Audit-1995: Survey of producer-related defects and carcass quality and quantity attributes SL Boleman, SJ Boleman, WW Morgan, DS Hale, DB Griffin, JW Savell, ... Journal of Animal Science 76 (1), 96-103, 1998 | 235 | 1998 |
| Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain CK Nielsen, FB Ross, S Lotfipour, KS Saini, SR Edwards, MT Smith Pain 132 (3), 289-300, 2007 | 226 | 2007 |
| The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal … MT Smith, PJ Cabot, FB Ross, AD Robertson, RJ Lewis Pain 96 (1), 119-127, 2002 | 225 | 2002 |
| Neurotrophins and neuropathic pain: role in pathobiology N Khan, MT Smith Molecules 20 (6), 10657-10688, 2015 | 217 | 2015 |
| Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease A Ansari, M Arenas, SM Greenfield, D Morris, J Lindsay, K Gilshenan, ... Alimentary pharmacology & therapeutics 28 (8), 973-983, 2008 | 213 | 2008 |
